Osteoporosis is the disease of the low bone mass and most often caused by the increase in the bone resorption that is not in sufficiently compensated for by the corresponding increase in the bone formation. As result gut-derived serotonin (GDS) inhibits the bone formation, we can asked whether hampering its is biosynthesis that could treat the osteoporosis through the anabolic mechanism (that is, by increasing bone formation).
We can synthesized and used the LP533401, a small of molecule inhibitor of the tryptophan hydroxylase-1 (Tph-1), the initial enzyme in the GDS biosynthesis. or the Oral administration of this small molecule once daily for up to the six weeks that acts as prophylactically or therapeutically, in the dose-dependent manner, to treat the osteoporosis in the ovariectomized the rodents because of an isolated increase in the bone formation. These results that provide a proof of the principle that have inhibiting the GDS biosynthesis that could become a new anabolic and treatment for osteoporosis.
To know more about osteoporosis. visit:
brainly.com/question/9389623
#SPJ4
The answer is; Population will crash
Answer:
From the given information, the transport of glucose in blood across the red blood cells takes place by facilitated diffusion, that involves the spontaneous passive-transport with the help of trans-membrane proteins or transporter proteins to move the ions or molecules down the concentration gradient.
While the transport of glucose in intestines take place via active transport mechanism. It takes place from gut into intestines. It occurs against the concentration gradient with the help of energy molecules like proteins.